Zevra Therapeutics, Inc. (ZVRA)
11.59
+0.19
(+1.67%)
USD |
NASDAQ |
May 29, 16:00
11.69
+0.10
(+0.86%)
After-Hours: 20:00
Zevra Therapeutics EPS Diluted (Quarterly) : 0.603 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -0.3954 |
| Journey Medical Corp. | -0.0817 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 36.32M |
| Revenue (Quarterly) | 36.22M |
| Total Expenses (Quarterly) | -0.097M |
| Enterprise Value | 485.68M |
| Gross Profit Margin (Quarterly) | 93.75% |
| Earnings Yield | 18.58% |
| Operating Earnings Yield | 1.49% |
| Normalized Earnings Yield | 26.28 |